Team Begins Defining Cancer Risk Patterns for Distinct BRCA1, BRCA2 Mutations | GenomeWeb

NEW YORK (GenomeWeb) – In a study appearing online today in the Journal of the American Medical Association, researchers began to tease apart the differences in breast and ovarian cancer risk for women carrying various BRCA1 and/or BRCA2 gene mutations.

The international team, which included members of the "Consortium of Investigators of Modifiers of BRCA" (CIMBA) group, considered documented disease patterns for tens of thousands of women with BRCA1 or BRCA2 mutations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.

Sponsored by

This webinar describes the optimization and validation of two commercially available next-generation sequencing assays that may be used to guide personalized cancer treatment. 

Sponsored by
Personal Genome Diagnostics

This webinar will provide an overview of genomic alterations that play a role in immunotherapy response.

Sponsored by

This online seminar will provide an overview of the use of liquid biopsies for cancer recurrence monitoring with a particular focus on colorectal cancer.

Sponsored by
Agilent Technologies

This webinar will discuss a target enrichment workflow for high-confidence detection of variants.